mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status

Mostrar otras versiones (1)

While mRNA vaccines are proving highly efficacious against SARS-CoV-2, it is important to determine how booster doses and prior infection influence the immune defense they elicit, and whether they protect against variants. Focusing on the T cell response, we conducted a longitudinal study of infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Neidleman, Jason, Luo, Xiaoyu, McGregor, Matthew, Xie, Guorui, Murray, Victoria, Greene, Warner C., Lee, Sulggi A., Roan, Nadia R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132283/
https://www.ncbi.nlm.nih.gov/pubmed/34013277
http://dx.doi.org/10.1101/2021.05.12.443888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132283/
https://www.ncbi.nlm.nih.gov/pubmed/34013277
http://dx.doi.org/10.1101/2021.05.12.443888

Ejemplares similares